Loading clinical trials...
Loading clinical trials...
A Multicenter, Non-Interventional Study Evaluating Bleeding Incidence, Health-Related Quality of Life, and Safety in Patients With Hemophilia A Under Standard-of-Care Treatment
Conditions
Interventions
Bypassing Agents
FVIII Replacement
Locations
35
United States
Santa Monica Oncology Center
Santa Monica, California, United States
University of Colorado Denver, Children's Hospital
Aurora, Colorado, United States
Georgetown Uni Medical Center; Lombardi Cancer Center
Washington D.C., District of Columbia, United States
Winship Cancer Institute
Atlanta, Georgia, United States
Tulane Uni Health Sciences Center
New Orleans, Louisiana, United States
Children's Hospital of Michigan; Pediatrics
Detroit, Michigan, United States
Start Date
May 26, 2015
Primary Completion Date
March 31, 2017
Completion Date
March 31, 2017
Last Updated
May 30, 2017
NCT06820515
NCT07226206
NCT05987449
NCT04563520
NCT04645199
NCT05936580
Lead Sponsor
Hoffmann-La Roche
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions